Anna Thorsø Larsen (Anna T Larsen)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Cardiovascular Disease

Top Venues

British journal of pharmacology

The Journal of pharmacology and experimental therapeutics

International journal of obesity (2005)

American journal of physiology. Endocrinology and metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Simone Anna Melander, Anna Thorsø Larsen, Morten Asser Karsdal, Kim Henriksen
Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long-acting dual amylin and calcitonin receptor agonist improves insulin-mediated glycaemic control and controls body weight. British journal of pharmacology (2024)
Anna Thorsø Larsen, Khaled Elhady Mohamed, Simone Anna Melander, Morten Asser Karsdal, Kim Henriksen
The enduring metabolic improvement of combining dual amylin and calcitonin receptor agonist and semaglutide treatments in a rat model of obesity and diabetes. American journal of physiology. Endocrinology and metabolism 327 (2) (2024)
Emilie A Petersen, Ida Blom, Simone A Melander, Mays Al-Rubai, Marina Vidotto, Louise Torp Dalgaard, Morten A Karsdal, Kim Henriksen, Steen Larsen, Anna Thorsø Larsen
DACRA induces profound weight loss, satiety control, and increased mitochondrial respiratory capacity in adipose tissue. International journal of obesity (2005) (2024)
Simone Anna Melander, Anna Thorsø Larsen, Morten Asser Karsdal, Kim Henriksen
Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long-acting dual amylin and calcitonin receptor agonist improves insulin-mediated glycaemic control and controls body weight. British journal of pharmacology 181 (12) (2024)
Simone Anna Melander, Anna Thorsø Larsen, Morten Asser Karsdal, Kim Henriksen
Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long-acting dual amylin and calcitonin receptor agonist improves insulin-mediated glycaemic control and controls body weight. British journal of pharmacology 181 (12) (2024)
Anna Thorsø Larsen, Nina Sonne, Kim V Andreassen, Morten A Karsdal, Kim Henriksen
Dose Frequency Optimization of the Dual Amylin and Calcitonin Receptor Agonist KBP-088: Long-Lasting Improvement in Food Preference and Body Weight Loss. The Journal of pharmacology and experimental therapeutics 373 (2) (2020)
Anna Thorsø Larsen, Nina Sonne, Kim Vietz Andreassen, Morten Asser Karsdal, Kim Henriksen
The Calcitonin Receptor Plays a Major Role in Glucose Regulation as a Function of Dual Amylin and Calcitonin Receptor Agonist Therapy. The Journal of pharmacology and experimental therapeutics 374 (1) (2020)